225
Participants
Start Date
April 12, 2019
Primary Completion Date
February 29, 2020
Study Completion Date
February 29, 2020
Dapagliflozin 10 MG Oral Tablet [Farxiga]
"The investigational medicinal product (IMP) is dapagliflozin10 mg given once daily (film coated tablets, oral use).~Dapagliflozin will be administered through out the planned intervention period of the study (12 weeks).~Dosage form and strength: 10 mg, Green, plain, diamond shaped, film coated tablet (orally)"
Placebo Oral Tablet
"The comparator will be placebo oral tablet matching dapagliflozin 10 mg. Placebo will be administered through out the planned intervention period of the study (12 weeks).~Dosage form and strength: Green, plain, diamond shaped, film coated tablet (orally). Does not contain active ingredient"
RECRUITING
Hospital Clínico San Carlos, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Universitario La Paz, Madrid
Lead Sponsor
Collaborators (1)
AstraZeneca
INDUSTRY
LM Diagnósticos S.L.
OTHER